| pubmed-article:19763024 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19763024 | lifeskim:mentions | umls-concept:C1882561 | lld:lifeskim |
| pubmed-article:19763024 | lifeskim:mentions | umls-concept:C0042401 | lld:lifeskim |
| pubmed-article:19763024 | lifeskim:mentions | umls-concept:C0162772 | lld:lifeskim |
| pubmed-article:19763024 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:19763024 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:19763024 | pubmed:dateCreated | 2009-9-18 | lld:pubmed |
| pubmed-article:19763024 | pubmed:abstractText | To clarify the underlying mechanisms of L-DOPA induced vasoconstriction in rat aorta. Methods: The effect of L-DOPA on phenylephrine-induced contractile force of blood vessels was examined in vitro using rat aortic ring preparations by isometric tension experiment. Involvement of nitric oxide (NO) in the effect of L-DOPA on vascular smooth muscle was studied by using N(omega)-Nitro-L-arginine (L-NNA), Sodium nitroprusside (SNP) in endothelium-intact and endothelium-denuded aortic rings. | lld:pubmed |
| pubmed-article:19763024 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19763024 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19763024 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19763024 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19763024 | pubmed:issn | 1349-6867 | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:TakahashiAkir... | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:NakayaYutakaY | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:SegawaHirokoH | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:MawatariKazua... | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:HaradaNagakat... | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:OshitaShuzoS | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:YasuiSonokoS | lld:pubmed |
| pubmed-article:19763024 | pubmed:author | pubmed-author:Yinhua | lld:pubmed |
| pubmed-article:19763024 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19763024 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:19763024 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19763024 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19763024 | pubmed:pagination | 120-9 | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:meshHeading | pubmed-meshheading:19763024... | lld:pubmed |
| pubmed-article:19763024 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19763024 | pubmed:articleTitle | L-DOPA inhibits nitric oxide-dependent vasorelaxation via production of reactive oxygen species in rat aorta. | lld:pubmed |
| pubmed-article:19763024 | pubmed:affiliation | Department of Anesthesiology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan. | lld:pubmed |
| pubmed-article:19763024 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19763024 | pubmed:publicationType | In Vitro | lld:pubmed |
